Callan Capital’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$912K Buy
17,936
+7
+0% +$354 0.07% 124
2024
Q4
$857K Buy
17,929
+20
+0.1% +$1K 0.06% 120
2024
Q3
$946K Sell
17,909
-15
-0.1% -$763 0.07% 118
2024
Q2
$886K Sell
17,924
-459
-2% -$22.8K 0.07% 116
2024
Q1
$922K Sell
18,383
-112
-0.6% -$5.41K 0.08% 102
2023
Q4
$886K Sell
18,495
-147
-0.8% -$6.58K 0.08% 98
2023
Q3
$815K Buy
18,642
+9
+0% +$412 0.09% 91
2023
Q2
$860K Buy
18,633
+13
+0.1% +$598 0.1% 83
2023
Q1
$841K Buy
18,620
+593
+3% +$26.4K 0.1% 86
2022
Q4
$757K Buy
18,027
+3,480
+24% +$141K 0.09% 91
2022
Q3
$529K Sell
14,547
-8,316
-36% -$339K 0.09% 80
2022
Q2
$933K Sell
22,863
-131,775
-85% -$5.86M 0.14% 60
2022
Q1
$7.43M Buy
+154,638
New +$7.53M 1.02% 20

Other funds holding VEA

Callan Capital's VEA Position: Q1 2025 in Review

Callan Capital increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 0.04% in Q1 2025, buying an estimated $354 and bringing the position to 17,936 shares worth $912K. The position accounts for 0.07% of the portfolio, ranked #124.

Callan Capital first reported a position in VEA in Q1 2022 and has held it in 13 quarters since. The position peaked at $7.43M in Q1 2022. 2,468 funds tracked by Wall St. Rank hold VEA as of Q1 2025.

  • Callan Capital held 17,936 shares of Vanguard FTSE Developed Markets ETF worth $912K as of Q1 2025.
  • Callan Capital bought 7 Vanguard FTSE Developed Markets ETF shares in Q1 2025, an estimated $354.
  • Vanguard FTSE Developed Markets ETF made up 0.07% of Callan Capital's portfolio in Q1 2025, its #124 holding.
  • Callan Capital first reported a position in Vanguard FTSE Developed Markets ETF in Q1 2022 and has held it in 13 quarters since.
  • Callan Capital's Vanguard FTSE Developed Markets ETF position peaked at $7.43M in Q1 2022.
  • 2,468 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.